Table 2.
Univariate analysis of survival outcomes
| Variable | PFS |
OS |
||
|---|---|---|---|---|
| 3 y (±95% CI) | P | 3 y (±95% CI) | P | |
| All patients | 76% | 95% | ||
| Age | .431 | .155 | ||
| <3 y | 69% | 92% | ||
| ≥3 y | 83% | 96% | ||
| Gender | .61 | .388 | ||
| Female | 77% | 94% | ||
| Male | 75% | 96% | ||
| Ethnicity | .576 | .697 | ||
| White | 78% | 94% | ||
| Non-White | 70% | 100% | ||
| Tumor grade | .509 | .336 | ||
| Differentiated | 83% | 93% | ||
| Anaplastic | 69% | 96% | ||
| Tumor location | .019 | .106 | ||
| Infratentorial | 68% | 93% | ||
| Supratentorial | 100% | 100% | ||
| Extent of resection | .001 | .001 | ||
| GTR | 88% | 97% | ||
| STR/NTR | 54% | 90% | ||
| Pre-RT Chemo | .594 | .464 | ||
| No | 81% | 95% | ||
| Yes | 64% | 93% | ||
Bolded type-face indicates statistical significant (P < .05).